Home Page Feature Archives - Page 2 of 54

Category: Home Page Feature

Support Team Life Without Lupus at NYC Marathon

February 2024 Are you looking for a challenge that can change people’s lives? Help run lupus into the ground by supporting our Team Life Without Lupus! Team Life Without Lupus is the official competitive team of the Lupus Research Alliance, the largest private funder of lupus research in the world. Through our team, amateur athletes […] Read More

Celebrating Patti Allen – A Woman Dedicated to Advocating for All with Lupus

March 4, 2024 Forget the old saying that March comes in like a lion and goes out like a lamb. At the Lupus Research Alliance, March is a time for intense, month-long action: when we salute Women’s History Month as well as advocate together on the Hill for lupus research funding. Spotlighting a strong and […] Read More

Lupus Research Alliance Announces Recipients of the Lupus Mechanisms and Targets Award

New York, NY, February 28. The Lupus Research Alliance (LRA) is pleased to announce the recent recipients of the Lupus Mechanisms and Targets Award (LMTA), whose research will investigate molecular pathways or targets that will lead to new or improved therapies for individuals with systemic lupus erythematosus (SLE). The LMTA provides investigators up to $600,000 […] Read More

Embracing the Arts to Educate and Advocate

February 1, 2024 In honor of Black History Month, we bring you the story of eloquent poet performer and lupus advocate Shanelle Gabriel. With a focus on the theme “African Americans and the Arts,” Black History Month is a perfect time to hear from Shanelle, a woman who uses her poetry and music to elevate […] Read More

Re-engineering Immune Cells Opens Door to Promising Therapy for Lupus Kidney Inflammation

Research Published in Nature Communications and Funded in Part by the Lupus Research Alliance Could Correct a Defect in Lupus NEW YORK, NY. February 6. Research featured in Nature Communications highlights a novel approach that re-engineers a person’s own immune cells to suppress the overactive immune system that occurs in lupus nephritis, a serious and potentially […] Read More

Lupus Research Alliance 2023 Dr. William E. Paul Distinguished Innovator Award Granted to Yale School of Medicine Researcher Akiko Iwasaki, Ph.D.

Research Will Explore How Ancient Viral Remnants in Our DNA Trigger Lupus NEW YORK, NY – January 30. The Lupus Research Alliance (LRA) is pleased to grant the 2023 Dr. William E. Paul Distinguished Innovator Award (DIA) to Akiko Iwasaki, Ph.D., Sterling Professor of Immunobiology at the Yale School of Medicine. Dr. Iwasaki will investigate […] Read More

Championing Patient Power in Lupus

January 24, 2024 Dr. Stacie Bell came to LRA’s clinical research affiliate Lupus Therapeutics (LT) one year ago to help fulfill the vision of an entire community united to triumph over a complex and confounding disease. She joined determined to work with the researchers, clinicians, biopharmaceutical companies, and most importantly the people with lupus and […] Read More

Lupus Research Alliance Mourns the Loss of Congresswoman Eddie Bernice Johnson

January 2, 2024 The national lupus community lost a passionate advocate with the passing of former Congresswoman Eddie Bernice Johnson (D-TX). As many have shared, Congresswoman Johnson was a woman of significant “firsts” – first Black head psychiatric nurse at the Dallas VA hospital, first nurse elected to Congress, first African American and first woman […] Read More

Lupus Therapeutics PALS Program Expansion

October 1, 2023 Call for Individuals to Serve as a Trained Peer Educator Lupus Therapeutics, the clinical affiliate of Lupus Research Alliance, is pleased to announce the expansion of the highly successful Patient Advocates for Lupus Studies (PALS) pilot program with an exciting request for people who have clinical trial experience as well as a […] Read More

LRA Highlights Groundbreaking Lupus Research at ACR Convergence 2023

This information is brought to you by the Lupus Research Alliance and Lupus Therapeutics and is not sponsored by, nor a part of, the American College of Rheumatology. 30+ presentations of studies funded by the LRA spanning a broad spectrum of research areas Positive results from Phase 2/3 clinical studies supported by LRA affiliate Lupus Therapeutics point to […] Read More